Stable loratadine spill resistant formulation
US7758877B2 · kind B2 · utility
3Cited by
14References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2005 |
| Grant date | Jul 20, 2010 |
| Priority date | — |
| Expiry date | Feb 2, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides for a storage stable pharmaceutical liquid suspension for oral administration having a pharmaceutically effective amount of an antihistamine. The storage stable suspension preferably contains loratadine. The present invention further provides a process of preparing the storage stable pharmaceutical liquid suspension as well as a method of treating a mammal with a therapeutically effective amount of loratadine in the stable pharmaceutical liquid suspension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.